A
Power Law company profile
AC Immune
Biotech & Life Sciences · Lausanne, Switzerland · Founded 2003 · IPO 2016 Thoroughbred
Valuation
$199M
Market cap · May/2026
Revenue
$3.3M
Latest reported FY
Featured in
$10B+ revenueThoroughbred · Power Law outcome
Investors
3 investors on AC Immune's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
Series B+
3 investors entered at this stage
Global footprint
Where AC Immune has talent and traffic
AI talent share
1.4%
of workforce is AI talent
(2 of 145 staff)
(2 of 145 staff)
Core AI21.38%
Other AI00%
Non-AI workforce14398.62%
Workforce by country
6
countries with
team presence
team presence
🇨🇭 Switzerland95%
🇫🇷 France2.2%
🇩🇪 Germany1.1%
🇺🇸 United States0.7%
🇦🇹 Austria0.7%
Web traffic by country
7.5K
monthly visits
across markets
across markets
🇺🇸 United States44%
🇬🇧 United Kingdom14.7%
🇨🇭 Switzerland12%
🇮🇳 India10.7%
🇫🇷 France6.7%
Market sentiment
What the market is saying about AC Immune
An AI-synthesized read of the highest-engagement posts about AC Immune on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See AC Immune on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.